Singapore - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingSingapore: Medicaments Containing Insulin Market 2024
Medicaments Containing Insulin Market Size in Singapore
In 2023, after four years of decline, there was significant decline in the Singaporean medicaments containing insulin market, when its value decreased by X% to $X. Over the period under review, consumption continues to indicate a tangible increase. As a result, consumption attained the peak level of $X. From 2014 to 2023, the growth of the market remained at a lower figure.
Medicaments Containing Insulin Production in Singapore
In value terms, medicaments containing insulin production surged to $X in 2023 estimated in export price. Overall, production, however, faced a precipitous setback. Over the period under review, production attained the peak level at $X in 2018; however, from 2019 to 2023, production failed to regain momentum.
Medicaments Containing Insulin Exports
Exports from Singapore
In 2023, shipments abroad of medicaments containing insulin but not antibiotics increased by X% to X kg, rising for the third consecutive year after two years of decline. Overall, exports posted a significant increase. Over the period under review, the exports hit record highs at X kg in 2018; however, from 2019 to 2023, the exports stood at a somewhat lower figure.
In value terms, medicaments containing insulin exports surged to $X in 2023. In general, exports showed significant growth. Over the period under review, the exports reached the maximum at $X in 2018; however, from 2019 to 2023, the exports stood at a somewhat lower figure.
Exports by Country
Malaysia (X kg) was the main destination for medicaments containing insulin exports from Singapore, accounting for a approx. X% share of total exports.
From 2013 to 2023, the average annual rate of growth in terms of volume to Malaysia stood at X%.
In value terms, Malaysia ($X) also remains the key foreign market for medicaments containing insulin but not antibiotics exports from Singapore.
From 2013 to 2023, the average annual rate of growth in terms of value to Malaysia stood at X%.
Export Prices by Country
The average medicaments containing insulin export price stood at $X per ton in 2023, reducing by X% against the previous year. Over the period under review, the export price, however, continues to indicate perceptible growth. The pace of growth appeared the most rapid in 2019 when the average export price increased by X%. The export price peaked at $X per ton in 2022, and then dropped dramatically in the following year.
As there is only one major export destination, the average price level is determined by prices for Malaysia.
From 2013 to 2023, the rate of growth in terms of prices for Malaysia amounted to X% per year.
Medicaments Containing Insulin Imports
Imports into Singapore
In 2023, overseas purchases of medicaments containing insulin but not antibiotics decreased by X% to X kg, falling for the third year in a row after three years of growth. In general, imports recorded a abrupt decrease. The most prominent rate of growth was recorded in 2015 when imports increased by X%. Imports peaked at X kg in 2013; however, from 2014 to 2023, imports remained at a lower figure.
In value terms, medicaments containing insulin imports stood at $X in 2023. Over the period under review, imports recorded a deep setback. The growth pace was the most rapid in 2015 with an increase of X% against the previous year. Over the period under review, imports reached the peak figure at $X in 2013; however, from 2014 to 2023, imports failed to regain momentum.
Imports by Country
India (X kg), the UK (X kg) and Australia (X kg) were the main suppliers of medicaments containing insulin imports to Singapore, together accounting for X% of total imports.
From 2012 to 2023, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by the UK (with a CAGR of X%), while imports for the other leaders experienced mixed trend patterns.
In value terms, the UK ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to Singapore, comprising X% of total imports. The second position in the ranking was taken by India ($X), with a X% share of total imports. It was followed by Australia, with a X% share.
From 2012 to 2023, the average annual rate of growth in terms of value from the UK stood at X%. The remaining supplying countries recorded the following average annual rates of imports growth: India (X% per year) and Australia (X% per year).
Import Prices by Country
The average medicaments containing insulin import price stood at $X per ton in 2023, standing approx. at the previous year. In general, the import price continues to indicate a buoyant increase. The pace of growth appeared the most rapid in 2014 an increase of X% against the previous year. Over the period under review, average import prices attained the maximum in 2023 and is expected to retain growth in the immediate term.
Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was the UK ($X per ton), while the price for India ($X per ton) was amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Australia (X%), while the prices for the other major suppliers experienced mixed trend patterns.
Source: IndexBox Platform
This report provides an in-depth analysis of the medicaments containing insulin market in Singapore. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale
Country coverage:
- Singapore
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Singapore
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
Recommended reports
This report provides an in-depth analysis of the medicaments containing insulin market in Asia.
This report provides an in-depth analysis of the medicaments containing insulin market in the U.S..
This report provides an in-depth analysis of the medicaments containing insulin market in China.
This report provides an in-depth analysis of the medicaments containing insulin market in the EU.
This report provides an in-depth analysis of the global medicaments containing insulin market.